European Research Infrastructure on Highly Pathogenic Agents
0679.481.238 · rovalta.com · 26/09/2026
European Research Infrastructure on Highly Pathogenic Agents
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOEuropean Research Infrastructure on Highly Pathogenic Agents is a International non-profit organization incorporated in 2017. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Ixelles. It employs on average 10,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0679.481.238
- Incorporation
- 01/08/2017
- Legal form
- International non-profit organization
- Registered office
- Rue du Trône 98 box B4
1050 Ixelles · BruxellesSee on map - Latest accounts
- 31/12/2025
- Average workforce
- 10,0 ETP
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,1 M € | -20.7% | 1,4 M € | +30.7% | 1 M € | +5.9% | 986,6 k € | +18.0% | 836 k € |
| EBITDA | 88,3 k € | -80.1% | 443,3 k € | +178% | 159,3 k € | -37.2% | 253,6 k € | -27.6% | 350,2 k € |
| Operating result | 87,2 k € | -80.3% | 441,6 k € | +182% | 156,8 k € | -37.5% | 250,8 k € | -28.1% | 348,8 k € |
| Net result | 113,9 k € | -75.9% | 473,2 k € | +198% | 159 k € | -36.0% | 248,5 k € | -28.1% | 345,8 k € |
| Balance sheet | |||||||||
| Equity | 2,1 M € | +5.9% | 1,9 M € | +32.3% | 1,5 M € | +12.2% | 1,3 M € | +23.5% | 1,1 M € |
| Total assets | 7,6 M € | +17.4% | 6,5 M € | -42.8% | 11,3 M € | -18.0% | 13,8 M € | +446% | 2,5 M € |
| Cash | 5,6 M € | +40.9% | 3,9 M € | -62.6% | 10,5 M € | -20.3% | 13,2 M € | +731% | 1,6 M € |
| Debts | 3 M € | +129% | 1,3 M € | -85.1% | 8,8 M € | -23.3% | 11,5 M € | +2049% | 536,4 k € |
| Other | |||||||||
| Workforce | 10,0 ETP | -9.1% | 11,0 ETP | +22.2% | 9,0 ETP | +20.0% | 7,5 ETP | +36.4% | 5,5 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/202510 active · 12 ended
Active mandates
Ended mandates
Other companies at this address
Rue du Trône 98 1050 Ixelles| Company | CBE no. |
|---|---|
ACQUIS● Active | 0739.590.158 |
Alzheimer Europe● Active | 0448.374.679 |
AMICE● Active | 0893.970.608 |
| 0534.481.777 | |
| 0658.709.875 | |
| 0697.708.033 | |
ECATS INTERNATIONAL Association● Active | 0831.300.490 |
ERTMS Accredited Labs● Active | 0845.471.497 |
Europa Pro Vita● Active | 0425.419.036 |
| 0806.744.347 | |
| 0833.142.106 | |
| 1022.708.117 | |
| 0687.812.944 | |
| 0628.655.020 | |
| 0889.462.185 | |
| 0845.274.430 | |
| 0545.953.612 | |
| 0811.573.363 | |
Laserlab-Europe● Active | 0701.800.839 |
| 1030.541.856 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/08/2026 | 28/05/2025 | 24/05/2024 | 11/05/2023 | 08/08/2022 |
| General meeting | 13/05/2026 | 16/04/2025 | 23/04/2024 | 17/04/2023 | 22/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 13/05/2026 | 27/08/2026 | French | |
| Abridged model | 31/12/2024 | 16/04/2025 | 28/05/2025 | French | |
| Abridged model | 31/12/2023 | 23/04/2024 | 24/05/2024 | French | |
| Abridged model | 31/12/2022 | 17/04/2023 | 11/05/2023 | French | |
| Abridged model | 31/12/2021 | 22/06/2022 | 08/08/2022 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202510 active · 12 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates23/08/2024DEMISSIONS, NOMINATIONS
- Mandates19/03/2024DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates04/12/2023DEMISSIONS, NOMINATIONS
- Mandates07/07/2023DEMISSIONS, NOMINATIONS
- Mandates18/04/2023DEMISSIONS, NOMINATIONS
- Mandates04/11/2022DEMISSIONS, NOMINATIONS
- Mandates29/12/2021DEMISSIONS, NOMINATIONS
- Registered office30/11/2021SIEGE SOCIAL
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025113,9 k €↓
- 2024Annual accounts 2024473,2 k €↑
- 2023Annual accounts 2023159 k €↓
- 2022Annual accounts 2022248,5 k €↓
- 2021Annual accounts 2021345,8 k €
- 01/08/2017IncorporationInternational non-profit organization